AKAN: Akanda Corp. Stock

SIC 2833 – Medicinal Chemicals and Botanical Products

Valuation
Market Cap ($M) 2.66
Enterprise Value ($M) -0.82
Book Value ($M) 4.28
Book Value / Share 1.88
Price / Book 0.62
NCAV ($M) 1.42
NCAV / Share 0.62
Price / NCAV 1.88

Profitability (mra)
Return on Invested Capital (ROIC) -0.88
Return on Assets (ROA) -0.41
Return on Equity (ROE) -0.90

Liquidity (mrq)
Quick Ratio 1.39
Current Ratio 1.39

Balance Sheet (mrq) ($M)
Current Assets 5.06
Assets 7.91
Liabilities 3.64
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.84
Operating Income -4.38
Net Income -4.10

Cash Flow Statement (mra) ($M)
Cash From Operations -3.98
Cash from Investing -1.02
Cash from Financing 8.99

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-15 1,962 10,590 18.53
2025-05-14 1,852 8,784 21.08
2025-05-13 3,148 23,605 13.34
2025-05-12 13,693 17,885 76.56

(click for more detail)

Similar Companies
ADVM – Adverum Biotechnologies, Inc. AGEN – Agenus Inc.
AIMD – Ainos, Inc. AKBA – Akebia Therapeutics, Inc.
ALDX – Aldeyra Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.